| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 4,778,000 | 4,218,000 | 4,231,000 | 3,452,000 | | Cost of Revenue | 3,637,000 | 3,029,000 | 2,763,000 | 3,184,000 | | | Gross Profit | 1,141,000 | 1,189,000 | 1,468,000 | 268,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 157,000 | 124,000 | 112,000 | (700,000) | | Non Recurring |
-
|
-
| 42,000 |
-
| | Others | 279,000 | 264,000 | 259,000 | 257,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 705,000 | 801,000 | 1,055,000 | 711,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (66,000) | (85,000) | 22,000 | (9,000) | | Earnings Before Interest And Taxes | 639,000 | 728,000 | 1,065,000 | 706,000 | | Interest Expense | 224,000 | 202,000 | 213,000 | 206,000 | | Income Before Tax | 415,000 | 526,000 | 852,000 | 500,000 | | Income Tax Expense | 167,000 | 178,000 | 344,000 | 200,000 | | Minority Interest |
-
| 12,000 | (12,000) | 4,000 | | | | Net Income From Continuing Ops | 248,000 | 348,000 | 508,000 | 300,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (2,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 248,000 | 348,000 | 508,000 | 298,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $248,000 | $348,000 | $508,000 | $298,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
